Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.323
-0.011 (-3.29%)
At close: Jun 26, 2026, 4:00 PM EDT
0.330
+0.007 (2.14%)
After-hours: Jun 26, 2026, 7:29 PM EDT
Werewolf Therapeutics Employees
Werewolf Therapeutics had 14 employees as of March 31, 2026. The number of employees decreased by 25 or -64.10% since the number was last reported on December 31, 2025.
Employees
14
Change
-25
Growth
-64.10%
Revenue / Employee
n/a
Profits / Employee
-$4,018,929
Market Cap
15.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Atossa Therapeutics | 16 |
| BioVie | 13 |
| Tempest Therapeutics | 5 |
| Exicure | 2 |
HOWL News
- 7 weeks ago - Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Werewolf Therapeutics Earnings release: Q1 2026 - Filings
- 3 months ago - Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation - TheFly
- 3 months ago - Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - TheFly
- 3 months ago - Werewolf Therapeutics to explore range of strategic alternatives - TheFly
- 3 months ago - Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics Annual report: Q4 2025 - Filings